Lapasanda, Argie C.
HRN: 13-42-30 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2023
AMPICILLIN 1GM (VIAL)
03/07/2023
03/13/2023
IV
800mg
Q6
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes